Citadel Advisors »

Senti Biosciences Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Senti Biosciences Ord (SNTI) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Senti Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Senti Biosciences Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Senti Biosciences Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $29k 44k 0.66

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Senti Biosciences Ord

NEA Management Company
8vc Gp I
ARK Investment Management
Vanguard Group
Intel Corporation
Omega Fund Management
Artal Group
Citadel Advisors
Two Sigma Investments
Harbour Investments
Millennium Management
Bank of America Corporation
Wolverine Asset Management
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Senti Biosciences Ord